HK1059290A1 - Isolating cells expressing secreted proteins - Google Patents
Isolating cells expressing secreted proteinsInfo
- Publication number
- HK1059290A1 HK1059290A1 HK04101951A HK04101951A HK1059290A1 HK 1059290 A1 HK1059290 A1 HK 1059290A1 HK 04101951 A HK04101951 A HK 04101951A HK 04101951 A HK04101951 A HK 04101951A HK 1059290 A1 HK1059290 A1 HK 1059290A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- poi
- isolating cells
- cells expressing
- secreted proteins
- expressing secreted
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 8
- 238000001514 detection method Methods 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26199901P | 2001-01-16 | 2001-01-16 | |
PCT/US2002/001208 WO2002057423A2 (fr) | 2001-01-16 | 2002-01-16 | Isolement de cellules exprimant des protéines sécrétées |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1059290A1 true HK1059290A1 (en) | 2004-06-25 |
Family
ID=22995765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04101951A HK1059290A1 (en) | 2001-01-16 | 2004-03-17 | Isolating cells expressing secreted proteins |
Country Status (10)
Country | Link |
---|---|
US (3) | US6919183B2 (fr) |
EP (1) | EP1392859B1 (fr) |
JP (1) | JP4323167B2 (fr) |
AT (1) | ATE325865T1 (fr) |
AU (1) | AU2002245272B2 (fr) |
CA (1) | CA2434802C (fr) |
DE (1) | DE60211329T2 (fr) |
HK (1) | HK1059290A1 (fr) |
IL (2) | IL156910A0 (fr) |
WO (1) | WO2002057423A2 (fr) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090137416A1 (en) | 2001-01-16 | 2009-05-28 | Regeneron Pharmaceuticals, Inc. | Isolating Cells Expressing Secreted Proteins |
EP1392859B1 (fr) * | 2001-01-16 | 2006-05-10 | Regeneron Pharmaceuticals, Inc. | Isolement de cellules exprimant des proteines secretees |
GB0118337D0 (en) * | 2001-07-27 | 2001-09-19 | Lonza Biologics Plc | Method for selecting antibody expressing cells |
NZ552851A (en) * | 2002-05-22 | 2008-09-26 | Biogen Idec Inc | Detection of a secreted polypeptide on the surface of a cell used as a marker for cellular productivity of the secreted polypeptide |
US20040067532A1 (en) * | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
US7771969B2 (en) | 2003-08-20 | 2010-08-10 | Celltech R&D Limited | Methods for obtaining antibodies |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
TW200808739A (en) | 2006-04-06 | 2008-02-16 | Novartis Vaccines & Diagnostic | Quinazolines for PDK1 inhibition |
JP2009535063A (ja) | 2006-05-04 | 2009-10-01 | アブマクシス・インコーポレイテツド | 異種間及び複数種提示系 |
EP2208792B1 (fr) | 2006-05-17 | 2015-05-06 | Hoffmann-La Roche AG | Polypeptide produisant des cellules |
US8067179B2 (en) | 2006-11-30 | 2011-11-29 | Research Development Foundation | Immunoglobulin libraries |
US8603950B2 (en) | 2007-02-20 | 2013-12-10 | Anaptysbio, Inc. | Methods of generating libraries and uses thereof |
WO2008118476A2 (fr) | 2007-03-26 | 2008-10-02 | Codon Devices, Inc. | Affichage de surface d'une cellule, criblage et production de protéines d'intérêt |
CA3187687A1 (fr) | 2007-09-14 | 2009-03-19 | Adimab, Llc | Bibliotheques d'anticorps synthetiques rationnelles et leurs utilisations |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
US8637435B2 (en) * | 2007-11-16 | 2014-01-28 | Merck Sharp & Dohme Corp. | Eukaryotic cell display systems |
KR20100093129A (ko) | 2007-12-20 | 2010-08-24 | 노파르티스 아게 | Pi 3 키나제 억제제로서 사용되는 티아졸 유도체 |
WO2009103753A1 (fr) * | 2008-02-20 | 2009-08-27 | Ablynx Nv | Procédés d'identification et/ou de tri de cellules par molécule sécrétée et coffrets pour la mise en œuvre de tels procédés |
JP5731827B2 (ja) | 2008-03-03 | 2015-06-10 | グライコフィ, インコーポレイテッド | 下等真核生物中での組換えタンパク質の表面ディスプレイ |
US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
WO2010064748A1 (fr) | 2008-12-04 | 2010-06-10 | Korea Research Institute Of Bioscience And Biotechnology | Criblage de protéines abondamment sécrétées et leur emploi en tant que partenaires de fusion dans la production de protéines recombinantes |
ES2661074T3 (es) | 2009-06-02 | 2018-03-27 | Regeneron Pharmaceuticals, Inc. | Células deficientes de fucosilación |
US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
US8278873B2 (en) * | 2009-09-10 | 2012-10-02 | Syntheon, Llc | Surgical sterilizer with integrated battery charging device |
CA2789446A1 (fr) | 2010-02-12 | 2011-08-18 | Oncomed Pharmaceuticals, Inc. | Procedes d'identification et d'isolement de cellules exprimant un polypeptide |
EP2390661B1 (fr) | 2010-05-02 | 2015-06-24 | Miltenyi Biotec GmbH | Supports d'ancrage/capture pour sélectionner ou analyser une cellule CHO en fonction d'un produit sécrété par la cellule CHO |
WO2011159847A2 (fr) | 2010-06-15 | 2011-12-22 | The Regents Of The University Of California | Conjugués du fragment d'anticorps fv à chaîne unique dirigé contre le récepteur orphelin 1 analogue au récepteur à la tyrosine kinase (ror1) et leurs procédés d'utilisation |
DK2593594T3 (en) | 2010-07-16 | 2017-12-11 | Adimab Llc | ANTIBODY LIBRARIES |
AR082418A1 (es) | 2010-08-02 | 2012-12-05 | Novartis Ag | Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico |
KR101291241B1 (ko) | 2010-11-04 | 2013-08-01 | 한국생명공학연구원 | 효모에서 인체 상피세포 성장인자를 대량 생산하는 방법 |
IL210093A0 (en) * | 2010-12-19 | 2011-06-30 | David Helman | Membrane bound reporter molecules and their use in cell sorting |
JP2014504503A (ja) | 2010-12-28 | 2014-02-24 | ゾーマ テクノロジー リミテッド | Pdzドメインを用いた細胞表面提示 |
DK3252076T3 (da) | 2011-01-14 | 2019-12-02 | Univ California | Diagnostisk anvendelse af antistoffer mod ror-1-protein |
CN103476777B (zh) | 2011-01-31 | 2015-05-27 | 诺瓦提斯公司 | 新杂环衍生物 |
CN102680679B (zh) * | 2011-03-15 | 2014-08-27 | 中国科学院上海生命科学研究院 | 检测单细胞特异性抗体分泌的细胞微孔芯片及其制备方法 |
PL2771342T3 (pl) | 2011-10-28 | 2016-11-30 | Nowe pochodne puryny i ich zastosowanie w leczeniu chorób | |
US9890378B2 (en) | 2012-05-11 | 2018-02-13 | Merck Sharp & Dohme Corp. | Surface anchored light chain bait antibody display system |
RU2630975C2 (ru) | 2012-05-16 | 2017-09-15 | Новартис Аг | Режим дозирования pi-3 киназы |
TW201823460A (zh) | 2012-05-29 | 2018-07-01 | 美商再生元醫藥公司 | 生產細胞株增強子 |
CN109369808B (zh) | 2012-08-24 | 2023-11-07 | 加利福尼亚大学董事会 | 用于治疗ror1癌症并抑制转移的抗体和疫苗 |
TWI675044B (zh) * | 2012-11-14 | 2019-10-21 | 美商再生元醫藥公司 | 重組細胞表面捕捉蛋白質 |
TWI682941B (zh) | 2013-02-01 | 2020-01-21 | 美商再生元醫藥公司 | 含嵌合恆定區之抗體 |
EA201591700A1 (ru) | 2013-03-14 | 2015-12-30 | Ридженерон Фармасьютикалз, Инк. | Гибридные белки апелина и их применение |
AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
GB201316644D0 (en) | 2013-09-19 | 2013-11-06 | Kymab Ltd | Expression vector production & High-Throughput cell screening |
CN105637085A (zh) | 2013-10-11 | 2016-06-01 | 瑞泽恩制药公司 | 代谢优化的细胞培养物 |
KR20160095035A (ko) | 2013-12-06 | 2016-08-10 | 노파르티스 아게 | 알파-이소형 선택성 포스파티딜이노시톨 3-키나제 억제제를 위한 투여 요법 |
AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
TW202330904A (zh) | 2015-08-04 | 2023-08-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
MX2018005298A (es) | 2015-11-02 | 2018-06-22 | Novartis Ag | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. |
WO2017132701A1 (fr) * | 2016-01-31 | 2017-08-03 | Shuang Zhang | Procédé de criblage d'anticorps |
KR20180104149A (ko) | 2016-02-04 | 2018-09-19 | 트리아니, 인코포레이티드 | 면역글로불린의 증대된 생성 |
WO2017203051A1 (fr) | 2016-05-26 | 2017-11-30 | University College Cork - National University Of Ireland, Cork | Bactérie gram positif modifiée |
EP3464332A1 (fr) | 2016-05-26 | 2019-04-10 | University College Cork - National University of Ireland, Cork | Procédés pour améliorer la prolifération de cellules mammaliennes |
IL299099A (en) | 2016-06-27 | 2023-02-01 | Univ California | Combinations of cancer treatments |
WO2018041740A1 (fr) | 2016-09-01 | 2018-03-08 | Bayer Pharma Aktiengesellschaft | Système d'affichage non covalent à l'aide de fimgt/dsf |
WO2018060833A1 (fr) | 2016-09-27 | 2018-04-05 | Novartis Ag | Schéma posologique pour l'alpelisib, un inhibiteur de la phosphatidylinositol 3-kinase spécifique de l'isoforme alpha |
JP6818134B2 (ja) | 2016-09-29 | 2021-01-20 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ポリペプチド産生細胞を選択するための改善された方法 |
GB201703418D0 (en) | 2017-03-03 | 2017-04-19 | Ge Healthcare Bio Sciences Ab | Method for cell line development |
GB201704115D0 (en) * | 2017-03-15 | 2017-04-26 | Oxford Genetics Ltd | Method of selecting for antibodies |
JP7287940B2 (ja) * | 2017-03-24 | 2023-06-06 | ランケナウ・インスティテュート・フォー・メディカル・リサーチ | ハイブリドーマによって分泌されるモノクローナル免疫グロブリンの誘導性細胞外膜捕捉のための方法及び組成物 |
EP3673044A1 (fr) | 2017-08-25 | 2020-07-01 | University College Cork-National University of Ireland, Cork | Utilisation debifidobacterium longum pour traiter l'obésité et permettre le contrôle du poids |
WO2019102018A2 (fr) | 2017-11-24 | 2019-05-31 | University College Cork, National University Of Ireland, Cork | Composition comprenant une cohorte de bactéries |
EP3604507A1 (fr) | 2018-07-30 | 2020-02-05 | University College Cork-National University of Ireland, Cork | Enzyme oméga-transaminase |
WO2020056456A1 (fr) * | 2018-09-17 | 2020-03-26 | South Australian Health And Medical Research Institute Limited | Procédés de production de protéines |
MX2021011956A (es) * | 2019-04-03 | 2021-12-15 | Regeneron Pharma | Metodos y composiciones para la insercion de secuencias codificantes de anticuerpos en un locus de puerto seguro. |
EP3783012A1 (fr) | 2019-08-20 | 2021-02-24 | Nuritas Limited | Peptide antimicrobien |
AU2020334196A1 (en) | 2019-08-20 | 2022-03-03 | Nuritas Limited | Peptides for treating muscle atrophy |
JP2022553367A (ja) | 2019-10-22 | 2022-12-22 | ニューリタス リミテッド | 非アルコール性脂肪肝の治療 |
JPWO2022190733A1 (fr) * | 2021-03-10 | 2022-09-15 | ||
EP4070670A1 (fr) | 2021-04-08 | 2022-10-12 | University College Cork-National University of Ireland Cork | Lacticaseibacillus paracasei em025-11 et ses utilisations |
JP2024514195A (ja) | 2021-04-14 | 2024-03-28 | ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク | 脳血管イベントおよび神経障害の治療 |
CA3214579A1 (fr) | 2021-04-14 | 2022-10-20 | Tom Moore | Psg1 destinee a etre utilisee dans le traitement de l'arthrose |
WO2023059800A2 (fr) | 2021-10-07 | 2023-04-13 | Regeneron Pharmaceuticals, Inc. | Systèmes et méthodes de modélisation et de régulation du ph |
CN118076885A (zh) | 2021-10-07 | 2024-05-24 | 里珍纳龙药品有限公司 | pH计校准与校正 |
WO2023167863A1 (fr) | 2022-03-02 | 2023-09-07 | Regeneron Pharmaceuticals, Inc. | Procédé de fabrication d'anticorps à titre élevé |
WO2024078729A1 (fr) | 2022-10-14 | 2024-04-18 | University College Cork - National University Of Ireland, Cork | Protéines exprimées par le placenta pour utilisation dans le traitement d'une lésion d'un tendon |
CN118006552A (zh) * | 2024-04-09 | 2024-05-10 | 暨南大学 | 一种抗原特异性浆细胞的筛选方法及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE237808T1 (de) * | 1992-10-21 | 2003-05-15 | Stefan Miltenyi | Direkte auswahl von zellen durch ein aussheidungsprodukt |
US6287784B1 (en) * | 1993-11-23 | 2001-09-11 | Genentech, Inc. | Kinase receptor activation assay |
HU230048B1 (hu) * | 1996-02-09 | 2015-06-29 | Abbvie Biotechnology Ltd | Humán TNFalfa-kötő antitestek alkalmazása |
CA2330678C (fr) | 1998-05-11 | 2009-04-07 | Miltenyi Biotec Gmbh | Methode de selection directe de cellules t antigenes-specifiques |
TR200504220T2 (tr) * | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
DE19900635A1 (de) * | 1999-01-11 | 2000-07-13 | Deutsches Krebsforsch | Selektion von monoklonalen Antikörpern |
EP1392859B1 (fr) * | 2001-01-16 | 2006-05-10 | Regeneron Pharmaceuticals, Inc. | Isolement de cellules exprimant des proteines secretees |
-
2002
- 2002-01-16 EP EP02713420A patent/EP1392859B1/fr not_active Expired - Lifetime
- 2002-01-16 AU AU2002245272A patent/AU2002245272B2/en not_active Expired
- 2002-01-16 WO PCT/US2002/001208 patent/WO2002057423A2/fr active Search and Examination
- 2002-01-16 AT AT02713420T patent/ATE325865T1/de active
- 2002-01-16 DE DE60211329T patent/DE60211329T2/de not_active Expired - Lifetime
- 2002-01-16 CA CA2434802A patent/CA2434802C/fr not_active Expired - Lifetime
- 2002-01-16 JP JP2002558477A patent/JP4323167B2/ja not_active Expired - Lifetime
- 2002-01-16 IL IL15691002A patent/IL156910A0/xx unknown
- 2002-01-16 US US10/050,279 patent/US6919183B2/en not_active Expired - Lifetime
-
2003
- 2003-07-14 IL IL156910A patent/IL156910A/en unknown
-
2004
- 2004-03-17 HK HK04101951A patent/HK1059290A1/xx not_active IP Right Cessation
-
2005
- 2005-04-05 US US11/099,158 patent/US20050186623A1/en not_active Abandoned
-
2006
- 2006-05-15 US US11/434,403 patent/US7435553B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4323167B2 (ja) | 2009-09-02 |
US7435553B2 (en) | 2008-10-14 |
JP2004520037A (ja) | 2004-07-08 |
ATE325865T1 (de) | 2006-06-15 |
US20050186623A1 (en) | 2005-08-25 |
WO2002057423A2 (fr) | 2002-07-25 |
AU2002245272B2 (en) | 2006-06-29 |
EP1392859A2 (fr) | 2004-03-03 |
CA2434802A1 (fr) | 2002-07-25 |
WO2002057423A3 (fr) | 2003-12-18 |
US6919183B2 (en) | 2005-07-19 |
EP1392859B1 (fr) | 2006-05-10 |
DE60211329D1 (de) | 2006-06-14 |
DE60211329T2 (de) | 2007-05-24 |
IL156910A (en) | 2009-08-03 |
US20060234311A1 (en) | 2006-10-19 |
CA2434802C (fr) | 2013-05-28 |
US20020168702A1 (en) | 2002-11-14 |
IL156910A0 (en) | 2004-02-08 |
EP1392859A4 (fr) | 2004-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1059290A1 (en) | Isolating cells expressing secreted proteins | |
WO2002034906A3 (fr) | Procede pour l'exposition de peptides et de polypeptides sur la surface cellulaire de bacteries | |
WO2003068947A8 (fr) | Electrodes de test comportant des couches de lipide/proteine immobilises et procedes de fabrication et d'utilisation associes | |
WO2002079490A3 (fr) | Codes-barres biologiques bases sur des particules a modification oligonucleotidique | |
ATE393228T1 (de) | Fusionsproteine und deren verwendung zur messung von protease-aktivität | |
WO2002004523A3 (fr) | Polypeptides d'anticorps artificiels | |
EP1499885A4 (fr) | Nouvelles proteines de fusion et analyses de detection de liaisons moleculaires | |
WO2003087129A3 (fr) | Peptides immunogenes et methode d'identification desdits peptides | |
WO2006107813A3 (fr) | Incorporation specifique a un site de phosphoserine dans des polypeptides a l'aide de la phosphoseryl-trna synthetase | |
DK1616878T3 (da) | Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse | |
WO2002086081A3 (fr) | Procedes et systemes permettant d'identifier des proteines | |
BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
WO1999009179A3 (fr) | Produits de recombinaison d'antigenes utiles dans la detection et la differenciation d'anticorps contre le vih | |
WO2006127822A3 (fr) | Polypeptides associes au domaine 1 de scytovirine | |
DK1576157T3 (da) | Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme | |
WO2003018797A3 (fr) | Procede et dispositif destines a l'expression, la purification et la detection proteiques | |
WO2003016904A3 (fr) | Etiquettes de sequence peptidique et leur procede d'utilisation | |
ATE310248T1 (de) | Biomolekülanalyse auf array-basis | |
WO2002064747A3 (fr) | Proteine de fusion avec recepteurs de la somatostatine | |
WO2003062444A3 (fr) | Systemes matriciels et procedes | |
WO2003033650A3 (fr) | Systeme a base de renilla reniformis recombinee servant au transfert d'energie par resonance de bioluminescence | |
HUP0101987A2 (hu) | Antibiotikus hatású proteinek és peptidek indukciója LAIT/sCD14-proteinnel | |
ATE307142T1 (de) | Zweifarbiges fluorimetrisches proteaseassay | |
DE60216721D1 (de) | Verfahren zum Nachweis von Protein-Proteininteraktionen in Membranen | |
WO2002081523A3 (fr) | Procede de preparation et de selection d'anticorps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20220115 |